[1] Zhu P, Liao W, Zhang WG, et al. A prospective study using propensity score matching to compare long-term survival outcomes after robotic-assisted, laparoscopic, or open liver resection for patients with BCLC stage 0-a hepatocellular carcinoma. Ann Surg, 2023, 277(1):103-111. [2] Zhou Q, Wang X, Li R, et al. Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis. J Gastroenterol, 2022, 57(9):684-694. [3] Rimola J, Sapena V, Brancatelli G, et al. Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria. Hepatology, 2022, 76(5):1318-1328. [4] 赵子路,唐少珊,彭珊珊,等.超声造影LI-RADS分类在小肝癌诊断中的应用价值.中国医科大学学报,2021,50(7):641-645. [5] 刘元锋,余晓梅,戴旭辉,等.超声造影对不同分化程度肝硬化合并小肝癌的诊断价值.中国超声医学杂志,2021,37(6):659-662. [6] Zuo D, Yang K, Wu S. Diagnostic performance of intravascular perfusion based contrast-enhanced ultrasound LI-RADS in the evaluation of hepatocellular carcinoma. Clin Hemorheol Microcirc, 2021, 78(4):429-437. [7] Khanna G, Chavhan GB, Schooler GR, et al. Diagnostic performance of LI-RADS version 2018 for evaluation of pediatric hepatocellular carcinoma. Radiology, 2021, 299(1):190-199. [8] Zopfs D, Rinneburger M, Pinto Dos Santos D, et al. Evaluating anemia using contrast-enhanced spectral detector CT of the chest in a large cohort of 522 patients. Eur Radiol, 2021, 31(6):4350-4357. [9] Ziayee F, Mueller-Lutz A, Gross J, et al. Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer. Diagn Interv Radiol, 2022, 28(2):108-114. [10] 卢先烨,刘宇杰,黄泽健,等.CEUS联合血清3项肿瘤标志物诊断原发性肝癌的价值.中国超声医学杂志,2022,38(10):1124-1127. [11] 魏博文,任峥,张亮,等.增强CT扫描评估TACE术治疗的原发性肝癌患者效果分析.实用肝脏病杂志,2022,25(4):603-604. [12] Zhou Y, Ding J, Qin Z, et al. Combination of CT/MRI LI-RADS with CEUS can improve the diagnostic performance for HCCs. Eur J Radiol, 2022, 149(1):1-10. [13] 梁雪,潘金彬,丁建民,等.超声造影LI-RADS与增强CT/MRI LI-RADS对肝微小病灶分类的一致性及差异性研究.中华超声影像学杂志,2021,30(11):938-943. [14] Vidili G, Arru M, Solinas G, et al. Contrast-enhanced ultrasound liver imaging reporting and data system: lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis. World J Gastroenterol, 2022, 28(27):3488-3502. [15] Yang D, Hu H, Li R, et al. The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B. Abdom Radiol (NY), 2022, 47(2):630-639. [16] Yu Q, Knight G, Karani K, et al. Real-time arteriography-directed percutaneous microwave ablation for small or poorly characterized hepatic lesions using hybrid Angio-CT. Abdom Radiol (NY), 2022, 47(4):1457-1463. [17] Yabe S, Sofue K, Hori M, et al. Added value of contrast enhancement boost images in routine multiphasic contrast-enhanced CT for the diagnosis of small (<20 mm) hypervascular hepatocellular carcinoma. Eur J Radiol, 2023, 160(1):1-9. [18] 林斌,周智鹏,戴文海,等.2018年版肝脏影像报告与数据系统肝胆期低信号对肝细胞癌的诊断效能.实用放射学杂志,2022,38(1):68-72,e98. [19] Narita K, Nakamura Y, Higaki T, et al. Iodine maps derived from sparse-view kV-switching dual-energy CT equipped with a deep learning reconstruction for diagnosis of hepatocellular carcinoma. Sci Rep, 2023, 13(1):3603-3614. [20] 李梦,严昆,尹珊珊,等.混合型肝癌超声造影表现与病理类型及分化程度的关系探讨.中国超声医学杂志,2022,38(1):49-52. |